Understanding how healthcare access affects ovarian cancer outcomes
A Role of Multilevel Healthcare Access Dimensions in Ovarian Cancer Disparities
This study is looking at how different racial groups experience varying survival rates from ovarian cancer and how access to good healthcare plays a role, aiming to find out what barriers might be preventing fair treatment for all patients.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10733044 on NIH RePORTER |
What this research studies
This research investigates the disparities in ovarian cancer survival rates among different racial groups, particularly focusing on how access to quality healthcare impacts these outcomes. It aims to analyze data from various healthcare access dimensions and their relationship with treatment adherence and survival rates. By examining the effects of structural racism and chronic stress on healthcare access, the study seeks to identify barriers that prevent equitable treatment for ovarian cancer patients. The research will utilize existing databases and longitudinal data to track healthcare access over time and its impact on patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include ovarian cancer patients, especially those from non-Hispanic Black and other minority backgrounds who may face barriers to accessing quality care.
Not a fit: Patients who are not diagnosed with ovarian cancer or those who have already received optimal treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and treatment strategies for ovarian cancer patients, particularly among underrepresented groups.
How similar studies have performed: Previous research has shown that addressing healthcare access disparities can lead to improved health outcomes, indicating that this approach has potential for success.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Akinyemiju, Tomi F — Duke University
- Study coordinator: Akinyemiju, Tomi F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.